| Wesley F Lister-winebrenner, PA-C | |
|
3940 Montclair Road, Suite 410, Birmingham, AL 35213-2421 | |
| (205) 879-7066 | |
| (205) 871-5066 |
| Full Name | Wesley F Lister-winebrenner |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 3940 Montclair Road, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659326478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | PA920 (Tennessee) | Secondary |
| 363A00000X | Physician Assistant | PA920 (Tennessee) | Primary |
| 363AS0400X | Physician Assistant - Surgical | 842 (Alabama) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Wesley F Lister-winebrenner, PA-C 3940 Montclair Road, Suite 410, Birmingham, AL 35213-2421 Ph: (205) 879-5066 | Wesley F Lister-winebrenner, PA-C 3940 Montclair Road, Suite 410, Birmingham, AL 35213-2421 Ph: (205) 879-7066 |
News Archive
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
A health care overhaul that would expand health insurance coverage to millions isn't free, and in addition to proposed cuts, bills would raise revenue with taxes and fees. "The typical family would be spared higher taxes from the House Democratic plan to overhaul health care, and their low-income neighbors could come out ahead," the Associated Press/Boston Globe reports.
Children can get five to 10 colds each year, so it's not surprising that adults often turn to over-the-counter cough and cold medicines to relieve their little ones' symptoms. But a new University of Michigan poll shows that many are giving young kids medicines that they should not use.
The Pacific Meso Center at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest.
› Verified 4 days ago